Methylmalonic acidemia is a rare inherited disorder.
Clinically it is characteriz ed by metabolic acidosis, vomiting, lethargy, muscular hypotonia, and failure to thrive (Oberholzer et al. 1967; Lindblad et al. 1968 ; Morrow et al. 1969a In 1972 Goodey and Gompertz investigated the mutase assay using leukocytes from patients with vitamin B12 responsive or unresponsive type of methylmalonic acidemia and reported that the mutase activity of leukocytes was not detected in normal subjects as well as in the patients when DBCC was not added to the assay media.
In 1976 Giorgio et al. made an investigation on the mutase activity of leukocytes from normal subjects and patients with methylmalonic acidemia, and reported that there was no increase in the enzyme activity over a basal activity in leukocytes from normal persons even when DBCC was added to the assay media.
A defective production of 14CO2 from propionate-3-14C by platelets was also observed in a patient with methylmalonic acidemia by Hsia et al. (1970) .
In 1969 Morrow et al. (1969b) measured the methylmalonyl-CoA mutase activity using liver biopsy specimens from patients with vitamin B12 responsive or unresponsive type of methylmalonic acidemia, and reported that in the case with vitamin B12 responsive type the mutase activity was restored to the normal when DBCC was added to the assay media.
In The methylmalonyl-CoA mutase activity of leukocytes was expressed as nmoles of 14C-succinate formed per mg protein per hr .
Methylmalonic acid in 24 hr urine specimens was estimated by the Frenkel and Kitchen's method (1975). CASE REPORT Case 1. H.T., a 6-month-old boy was referred to the University Hospital because of frequent episodes of lethargy and muscular hypotonia.
The patient was born to healthy but consanguineous parents after an uneventful pregnancy and delivary, weighing 2,850 g. There were two healthy siblings in his family. He had been well until the age of 4 months, when vomiting, lethargy and dehydration developed after an acute upper respiratory infection. At that time a positive reaction to urinary acetone and large amounts of methylmalonic acid in urine (1,390 mg/24 hr) were found. Clinical symptoms and signs were improved by an intravenous fluid therapy including sodium bicarbonate and by feeding on a diet low in protein (approximately 2 g/kg/day).
On admission (when 6 months old) physical examination revealed a floppy and pale infant with apathetic facies. His body weight was 6,450 g (normal 7,300 g), height 62 cm (normal 65.2 cm), circumference of the head 43.5 cm (normal 43.1 cm), and that of the chest 39.0 cm (normal 42.0 cm). The liver was palpable four finger breadths below the right costal margin. He was markedly hypotonic, but other neurologic abnormalities were not found. Episodes of metabolic acidosis with anorexia, vomiting and lethargy developed again at the age of 3 and 1 /2 months, with recovery by an intravenous fluid therapy including sodium bicarbonate, During the acidotic episodes, hyper ammonemia and neutropenia were observed.
On admission, when 4 months old, physical examination revealed a floppy female infant. The body weight was 6.0 kg (normal 6.4 kg), length 58.4 cm (normal 61.3 cm), circumference of the head 39.6 cm (normal 41.6 cm). The liver was palpable one finger breadth below the right costal margin, but the spleen not. There was generalized muscular hypotonia, but no other neurological abnormalities. At the age of two months, he sucked poorly, then tachypnea, lethargy, involuntary movements of extremities, and generalized convulsions developed. At that time serum glycine was 7.37 mg/100 ml, the plasma bicarbonate content was 5.3 mEq/liter, and there were neutropenia and failure to thrive. Clinical conditions were improved by an intravenous fluid therapy including sodium bicarbonate. About one week after the recovery, urinary excretion of methyl malonic acid was found to be 24.9 mg/24 hr. The urinary cyanide-nitroprusside reaction was negative.
Even though urinary excretion of methylmalonic acid was less than that in previously reported cases with methylmalonic acidemia, he was then treated with a diet low in valine, isoleucine, threonine and methionine (specially prepared by Yukizirushi Co. Ltd., Tokyo) and oral administration of cyanocoblamin , 1 mg daily. These therapy was continued for following 5 weeks, during which period the patient was free from vomiting, lethargy, and convulsions.
At the end of five weeks on the therapy with the low protein diet and an oral administration of vitamin B12, only the vitamin B12 administration was dis continued. Three months later, he refused food, and showed involuntary movements of the head, vomiting, acidosis and no interest to his surroundings. At this time urinary excretion of methylmalonic acid was found to be 136 mg/24 hr and serum vitamin B12 1,226pg/ml. An intravenous fluid therapy including sodium bicarbonate resulted in clinical improvement. At this stage blood samples were obtained for assay of leukocyte mutase activity.
Urinary excretion of methylmalonic acid after an oral valine load in Case 3 was examined in the following way: Twenty four-hr urine was collected before and after an oral load with L-valine (100 mg per kg body weight) and assayed for methylmalonic acid, with results of 9.3 mg and 143 mg/24 hr, respectively. After intramuscular injections of cyanocobalamin, 1 mg per day for successive 10 days, the oral valine loading was done again. In this case, urinary methylmalonic acid was found to be 23.8 mg and 15.1 mg/24 hr before and after the valine load, respectively, indicating that there was practically no difference between the two tests.
SPECIAL STUDIES
Methylmalonyl-CoA mutase activity of leukocytes (Table 1) The The methylmalonyl-CoA mutase activities of leukocytes, when measured without the in vitro addition of DBCC, were found to be one tenth or less of the normal in Cases 1, 2 and 3.
When the enzyme assay was carried out with the in vitro addition of DBCC, the mutase activity was restored to be within the normal range in only Case 3, but not in Cases 1 and 2, indicating that Case 3 was of the vitamin B12 responsive type of methylmalonic acidemia.
The enzyme assay with the in vitro addition of DBCC revealed that the mutasee activities of leukocytes from both parents of Cases 1 and 2 were approximately half the normal and that from the second elder brother of Case 1 was 26.4% of the normal value.
DISCUSSION
Clinical pictures of methylmalonic acidemia, including acidosis, vomiting, lethargy, muscular hypotonia and failure to thrive (Oberholzer et al. 1967; Lindblad et al. 1967; Morrow et al. 1969a) were observed in all the three cases of ours. But it was noticed that in Case 3, the amount of methylmalonic acid excreted in urine (9.3-14.30 mg/24 hr) was less than those for the cases reported as methylmalonic acidemia except for the following five cases: Giorgio's two adult cases (1976) which were free from clinical findings except for those of diabetes mellitus and showed urinary methylmalonic acid of 115 mg or less/24 hr, and Garnica's three infants (1976) which showed intermittent acidosis and urinary excretion of methylmalonic acid of 145 mg or less/24 hr.
In our three cases with methylmalonic acidemia, Cases 1 and 2 showed no change in urinary excretion of methylmalonic acid after intramuscular injections of cyanocobalamin. However in Case 3, there was a marked decrease in urinary methylmalonic acid excretion following an oral load with L-valine when tested after pretreatment with intramuscular injections of cyanocobalamin, 1 mg per day for successive ten days.
The results of the assay for methylmalonyl-CoA mutase of leukocytes with the in vitro addition of DBCC revealed that methylmalonic acidemia in Cases 1 and 2 belonged to the B12 unresponsive type and that in Case 3 to the B12 responsive type .
These results of ours were consistent with those of Morrow et al . (1969b) , who showed that the methylmalonyl-CoA mutase activity of the liver from patients with the vitamin B12 responsive methylmalonic acidemia was restored to the normal when the enzyme assay was done with the in vitro addition of DBCC .
The similar tendency with respect to the enzyme activity was reported by Rosenberg et al. (1969) The mutase activities of leukocytes from both parents of Cases 1 and 2 were found to be half the normal when the enzyme assay was carried out with the in vitro addition of DBCC. Moreover, there was no overlap in the mutase activity of leukocytes between obligate heterozygotes and normal subjects. The mode of transmittance was reported as an autosomal recessive for both the apoenzyme defect and the vitamin B12 responsive variant (Morrow et al. 1969a ). Thus the assay technique for the mutase activity of leukocytes described here could be of value for the detection of heterozygotes with the vitamin B12 unresponsive type. The second elder brother of Case 1, who was clinically normal, showed a mutase activity 26.4% of the normal, suggesting that he was also a heterozygote. Morrow (1974) described, however, that he failed to make differentiation between heterozygotes of methylmalonic acidemia and controls by the mutase assay of leukocytes or fibroblast. Discrepancy between Morrow's results and ours remains unexplained because detailed procedures of assay for the mutase activity were not described in the Morrow's report.
In our assay for the mutase activity, we employed 0.074 mM DL-methyl malonyl-CoA as the substrate and therefore the concentration of L-methylmalonylCoA should be considerably lower than the Km value which had been reported to be 0.24 mM for the mutase from sheep liver (Cannata et al. 1965 ). Consequently, the rate of formation of 14C-succinate from 14C-racemic methylmalonyl-CoA under our assay conditions would be influenced considerably by the racemase activity in the enzyme preparation used. In other words, it is expected that when our method of assay of the mutase activity was applied to leukocytes from patients with racemase defect, the mutase activity would appear to be less than the normal. These situations raise the question that both the parents of Case 1 and 2 might have been deficient in the racemase activity, for, as shown in Table 1 , the "mutase" activity of leukocytes from both parents from Case 1 and 2 were found to be half the normal when DBCC was added to the assay medium.
However, this does not appear to be the case because urinary excretion of methylmalonic acid in both the parents was found to be within normal limits.
